Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers.
Share:
More In Science
California Gov. Gavin Newsom, China President Xi Jinping Meet Over Climate
California Governor Gavin Newsom met with Chinese President Xi Jinping in an effort to promote climate co-operation
Your Wednesday Weather Forecast for Oct. 25, 2023
Cheddar News checks in with your coast-to-coast weather forecast for Wednesday, Oct. 25, 2023.
Be Well: How Muscle Building Exercises Can Offset Effects of Chronic Illnesses
Understanding chronic illness and their link to muscle and bone health.
Be Well: Building Core, Hip and Glute Strength
Building core hip and shoulder strength.
New Cervical Cancer Treatment a 'Breakthrough'
A new study presented at the European Society of Medical Oncology conference could provide a breakthrough in treatment for cervical cancer.
First Snowfall of the Season Expected This Week
The first snowfall is officially on its way with snow expected to fall in the Northwest and Northern Plain regions as early as Tuesday.
EPA Proposes Banning Cancer-Causing Chemical
The Environmental Protection Agency is proposed banning a cancer-causing chemical that can be found in products like car break cleaners, laundry spot removers and some arts and crafts sprays.
A New RSV Shot for Infants Is in Short Supply
The Centers for Disease Control and Prevention issued a warning to doctors, saying a key drug used to prevent respiratory infections in babies is in limited supply.
